Behbahani Ali's Form 4 filing
Monte Rosa Therapeutics, Inc. (GLUE) · filed Jul 6, 2026
- Accession no.
- 0001193125-26-296490
- Filed
- Jul 6, 2026, 5:57 PM ET
- Trade date
- Jul 1, 2026
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Behbahani AliCIK 0001613867 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Common Stock | JOtherDisposed | −1,000,000 | $0.00 | $0 | 6,692,298 | Indirect | |
| Jul 1, 2026 | Common Stock | JOtherAcquired | +15,000 | $0.00 | $0 | 15,000 | Indirect | |
| Jul 1, 2026 | Common Stock | JOtherDisposed | −15,000 | $0.00 | $0 | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.